|
|
42
|
|
|
B421AB
|
|
|
APO-DAPAGLIFLOZIN 5MG TAB (APO)
|
|
|
DAPAGLIFLOZIN
|
|
|
APO-DAPAGLIFLOZIN
|
|
|
30'S
|
|
|
A
|
|
|
10.33
|
|
|
0.34
|
|
|
5MG
|
|
|
TAB
|
|
|
30
|
|
|
BOTT
|
|
|
APO
|
|
|
APOTEX INC.
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|